About VersaPharm
VersaPharm is a company based in Marietta (United States) founded in 1995 was acquired by Akorn in May 2014. VersaPharm has completed 1 acquisition, including Xanodyne Pharmaceuticals.
- Headquarter Marietta, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Akorn
(May 09, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of VersaPharm
Detailed funding history for VersaPharm
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in VersaPharm
VersaPharm has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Akorn.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Injectable and ophthalmic pharmaceutical products were manufactured across therapeutic areas.
|
Locked | Locked | Locked |
Investor details for VersaPharm
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VersaPharm
VersaPharm has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Xanodyne Pharmaceuticals.
Investment portfolio details for VersaPharm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of drugs for women's health and pain management
|
Locked | Locked | 2001 | Locked |
Complete acquisition details for VersaPharm
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - VersaPharm
Detailed financials for VersaPharm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Versapharm Comparisons
Peer comparison for VersaPharm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VersaPharm
Detailed competitors of VersaPharm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Versapharm
Complete news archive for VersaPharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VersaPharm
VersaPharm was founded in 1995.
VersaPharm is headquartered in Marietta, United States. It is registered at Marietta, Georgia, United States.
VersaPharm was founded in 1995 in Marietta, United States, focusing on the generic pharmaceuticals sector. Operations centered on developing and marketing products across categories including dermatology, tuberculosis, and hemophilia. FDA approval was secured for generic injectable rifampin. The company was acquired by Tailwind Capital in 2007 and later sold to Akron, reflecting shifts in ownership within the industry.
VersaPharm has made 1 acquisition, including Xanodyne Pharmaceuticals.
VersaPharm has 1 investor. Key investors include Akorn.